Track Eikon Therapeutics Common Stock's operating income ($-350M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowAs of Sep 30, 2026
Trailing 12 months ending Sep 30, 2026
As of the most recent data (September 2026), EIKN shows a operating income of $-350M. Scroll down for historical charts and peer comparison views.
Tracking EIKN's operating income over time shows whether Eikon Therapeutics Common Stock is scaling, shrinking, or reshaping that part of the business. The current reading is $-350M Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this operating income page, Stockcircle has Eikon Therapeutics Common Stock's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect operating income (currently $-350M) with ownership activity and broader fundamentals.
Eikon Therapeutics Common Stock's operating income is $-350M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.